about
Inhibitory effect of bufalin and cinobufagin on steroidogenesis via the activation of ERK in human adrenocortical cellsAdrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failureHeart failure in patients with chronic kidney disease: a systematic integrative reviewMineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart FailureSimilar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signalingAn adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivoMineralocorticoid receptor antagonists and endothelial functionManagement of end-stage heart failure: a perspective on the Arab Gulf statesAldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action.Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy.Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.Hip fractures and heart failure: findings from the Cardiovascular Health Study.Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.Aldosterone receptor antagonists: effective but often forgotten.Disordered aldosterone-volume relationship in end-stage kidney disease.Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.Common genetic variants of the human steroid 21-hydroxylase gene (CYP21A2) are related to differences in circulating hormone levels.Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivoAssociation of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentCardiorenal syndrome in acute heart failure syndromes.Renin and cardiovascular disease: Worn-out path, or new direction.Eplerenone--a novel selective aldosterone blocker.Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.Regulation of circulating progenitor cells in left ventricular dysfunction.Aldosterone: a forgotten mediator of the relationship between psychological stress and heart diseaseEffects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials.Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison.Heart failure and the brain: new perspectives.Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses.Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.Management of acute decompensated heart failure in the emergency department.Novel pharmacological treatments for heart failure.
P2860
Q24605993-FB40DE96-BA35-4C71-9BB5-06CB1F8567BDQ26785936-DB2F7B78-0BF8-442F-961E-0EBD6711477DQ26824149-3E170816-6AE1-4AF4-A5FA-52165059069BQ28066549-8F74B593-832E-44A7-A8A1-6F8DB030DC58Q28565760-DD78BB0D-890B-4841-9264-CD32445295FCQ28578913-77FA3D02-A8BF-4970-BF33-6ABC40B122F0Q28645984-E7BDA02C-055F-4564-BED7-C1D8A097A1F2Q28751716-2C75C0B2-F367-405A-9B37-2F51B6817F19Q30410186-1FA727A0-D3EC-4248-B2AC-6FF8CA186C63Q30619167-93608C07-6D49-4EC9-AA57-875353045BDAQ33511929-C69BC29F-FC4B-40B5-9B79-772D12408046Q33568103-4C5D4827-4137-4286-AD2B-ABD5EE7414F0Q33583861-97794839-A31E-4876-A8BF-A39F94CF572FQ33629543-20F41E26-7A90-4A01-8422-F70E2DFEA7F6Q33688485-A7545BB8-6476-45F8-B14B-87EBFA4BF63DQ33764028-6673F4FA-1174-45BA-AC6E-5137D6F913B4Q33890786-8FC278AC-81E1-4FF1-B1F8-35B8D0D1ADDBQ34061092-B4CE24E6-2C5D-4D6B-8E88-A66F53106F49Q34117919-D597D145-D429-4191-8043-904843B5A95AQ34166429-A94C91D4-E442-48D7-B2BD-3579FC6BB183Q34343068-F8D3DBCB-CC6D-4D32-BCBC-901298756C10Q34375466-D31D2D91-AB48-4948-9F65-D6DDD3510018Q34431544-69E9EC9C-DD92-4380-B8E1-BB84A33A03D3Q34501952-B6E16CBF-D9C9-4C58-87EA-3036BCD81176Q34664894-F7453D54-16E4-467C-A9FE-5E5F60D3C360Q34665867-E0B81FE6-B7FC-414E-BE55-94F75726A2E1Q34801804-B808AC48-12EB-44EF-91C7-84AB68D594EBQ34874363-55DBFF27-4E7B-455D-B43E-722199073FFCQ34925428-9FB25058-EE4D-471E-B6E0-2A1E5698BF8FQ34981416-6E05EA50-8575-4359-8B4C-4D66BAD2FA42Q34989233-C38CB963-5EE3-48D3-A6CE-55BFEDAACABBQ34997222-A96E68DF-2D65-47D3-9469-F1E605FA8879Q35018046-5D3E297B-3D23-453C-8C45-8089ADC5ECA4Q35024828-2A9AC31B-6BDF-4166-AD95-70F85E726D5FQ35046024-203400E6-2AE8-432D-B131-455D1F47CA23Q35048957-05C5A22D-E448-4867-AA89-37CEA1908FF7Q35087035-C8E1C1C7-7BFC-432B-A655-A20081496C28Q35164124-E30F6641-89D2-40DF-B45B-6F086ED2C214Q35561935-F124C3F9-318C-4492-A15D-055E697B50E6Q35570949-198CFBB5-D716-4BD7-8F73-16D8158DFE78
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aldosterone in congestive heart failure.
@ast
Aldosterone in congestive heart failure.
@en
Aldosterone in congestive heart failure.
@nl
type
label
Aldosterone in congestive heart failure.
@ast
Aldosterone in congestive heart failure.
@en
Aldosterone in congestive heart failure.
@nl
prefLabel
Aldosterone in congestive heart failure.
@ast
Aldosterone in congestive heart failure.
@en
Aldosterone in congestive heart failure.
@nl
P356
P1476
Aldosterone in congestive heart failure.
@en
P2093
P304
P356
10.1056/NEJMRA000050
P407
P577
2001-12-01T00:00:00Z